Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

USA - NYSE:ACVA - US00091G1040 - Common Stock

9.51 USD
+0.15 (+1.6%)
Last: 10/24/2025, 8:07:53 PM
9.51 USD
0 (0%)
After Hours: 10/24/2025, 8:07:53 PM
Fundamental Rating

3

ACVA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Commercial Services & Supplies industry. While ACVA seems to be doing ok healthwise, there are quite some concerns on its profitability. ACVA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACVA had negative earnings in the past year.
ACVA had a positive operating cash flow in the past year.
In the past 5 years ACVA always reported negative net income.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -5.65%, ACVA is not doing good in the industry: 67.07% of the companies in the same industry are doing better.
ACVA has a Return On Equity of -14.32%. This is in the lower half of the industry: ACVA underperforms 63.41% of its industry peers.
Industry RankSector Rank
ROA -5.65%
ROE -14.32%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

ACVA's Gross Margin of 53.10% is amongst the best of the industry. ACVA outperforms 93.90% of its industry peers.
ACVA's Gross Margin has improved in the last couple of years.
ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACVA has more shares outstanding
Compared to 5 years ago, ACVA has more shares outstanding
Compared to 1 year ago, ACVA has a worse debt to assets ratio.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ACVA has an Altman-Z score of 1.51. This is a bad value and indicates that ACVA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.51, ACVA is doing worse than 63.41% of the companies in the same industry.
ACVA has a debt to FCF ratio of 3.13. This is a good value and a sign of high solvency as ACVA would need 3.13 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.13, ACVA is doing good in the industry, outperforming 71.95% of the companies in the same industry.
A Debt/Equity ratio of 0.42 indicates that ACVA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.42, ACVA is in line with its industry, outperforming 58.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Altman-Z 1.51
ROIC/WACCN/A
WACC8.21%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ACVA has a Current Ratio of 1.59. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
ACVA's Current ratio of 1.59 is in line compared to the rest of the industry. ACVA outperforms 56.10% of its industry peers.
ACVA has a Quick Ratio of 1.59. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
ACVA's Quick ratio of 1.59 is fine compared to the rest of the industry. ACVA outperforms 64.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

ACVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.02%, which is quite good.
ACVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.08%.
Measured over the past years, ACVA shows a very strong growth in Revenue. The Revenue has been growing by 42.93% on average per year.
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)30.08%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%

3.2 Future

The Earnings Per Share is expected to grow by 45.81% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.75% on average over the next years. This is quite good.
EPS Next Y41.21%
EPS Next 2Y39.74%
EPS Next 3Y38.29%
EPS Next 5Y45.81%
Revenue Next Year21.16%
Revenue Next 2Y20.14%
Revenue Next 3Y19.54%
Revenue Next 5Y19.75%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACVA. In the last year negative earnings were reported.
Also next year ACVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACVA indicates a somewhat cheap valuation: ACVA is cheaper than 65.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 27.47
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

ACVA's earnings are expected to grow with 38.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.74%
EPS Next 3Y38.29%

0

5. Dividend

5.1 Amount

No dividends for ACVA!.
Industry RankSector Rank
Dividend Yield N/A

ACV AUCTIONS INC-A

NYSE:ACVA (10/24/2025, 8:07:53 PM)

After market: 9.51 0 (0%)

9.51

+0.15 (+1.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners105.31%
Inst Owner Change0.6%
Ins Owners2.45%
Ins Owner Change-10.23%
Market Cap1.64B
Revenue(TTM)707.24M
Net Income(TTM)-64281000
Analysts84
Price Target19.85 (108.73%)
Short Float %6.53%
Short Ratio3.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.78%
Min EPS beat(2)23.94%
Max EPS beat(2)35.62%
EPS beat(4)3
Avg EPS beat(4)16.19%
Min EPS beat(4)-9.21%
Max EPS beat(4)35.62%
EPS beat(8)6
Avg EPS beat(8)9.46%
EPS beat(12)10
Avg EPS beat(12)18.85%
EPS beat(16)13
Avg EPS beat(16)15.67%
Revenue beat(2)0
Avg Revenue beat(2)-2.4%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-1.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)4.71%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)4
Avg Revenue beat(12)0.08%
Revenue beat(16)7
Avg Revenue beat(16)1.14%
PT rev (1m)-2.1%
PT rev (3m)-15.86%
EPS NQ rev (1m)-5.91%
EPS NQ rev (3m)-33.14%
EPS NY rev (1m)-2.47%
EPS NY rev (3m)2.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.31
P/FCF 27.47
P/OCF 16.66
P/B 3.65
P/tB 15.85
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.35
FCFY3.64%
OCF(TTM)0.57
OCFY6%
SpS4.11
BVpS2.61
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.65%
ROE -14.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.1%
FCFM 8.43%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Debt/EBITDA N/A
Cap/Depr 92.97%
Cap/Sales 5.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 1.51
F-Score6
WACC8.21%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y41.21%
EPS Next 2Y39.74%
EPS Next 3Y38.29%
EPS Next 5Y45.81%
Revenue 1Y (TTM)30.08%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%
Revenue Next Year21.16%
Revenue Next 2Y20.14%
Revenue Next 3Y19.54%
Revenue Next 5Y19.75%
EBIT growth 1Y26.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.7%
EBIT Next 3Y66.33%
EBIT Next 5Y45.06%
FCF growth 1Y1113.5%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y373.93%
OCF growth 3Y-8.47%
OCF growth 5YN/A

ACV AUCTIONS INC-A / ACVA FAQ

What is the ChartMill fundamental rating of ACV AUCTIONS INC-A (ACVA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACVA.


What is the valuation status of ACV AUCTIONS INC-A (ACVA) stock?

ChartMill assigns a valuation rating of 2 / 10 to ACV AUCTIONS INC-A (ACVA). This can be considered as Overvalued.


What is the profitability of ACVA stock?

ACV AUCTIONS INC-A (ACVA) has a profitability rating of 2 / 10.


How financially healthy is ACV AUCTIONS INC-A?

The financial health rating of ACV AUCTIONS INC-A (ACVA) is 4 / 10.


Can you provide the expected EPS growth for ACVA stock?

The Earnings per Share (EPS) of ACV AUCTIONS INC-A (ACVA) is expected to grow by 41.21% in the next year.